文献速递肿瘤 PET/CT

雌激素受体阳性乳腺癌患者肿瘤特征与18F-FDG PET的SUV、代谢肿瘤体积、TLG及纹理特征的关联

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-02-10

该前瞻性研究纳入171例无远处转移的较大或局部晚期雌激素受体阳性乳腺癌患者,新辅助化疗前行18F-FDG PET,评估纹理特征与SUV、代谢肿瘤体积(MTV)、总病灶糖酵解(TLG)及肿瘤特征的关系,并分析其预测新辅助化疗病理反应的能力。纹理特征与SUV相关性差、与MTV相关性高,且与组织学类型显著相关;SUVmax和TLG能预测病理反应,纹理特征未能预测。

要点

  • 纹理特征与SUVmax相关性差,与MTV相关性高(Spearman系数0.99、0.86、-0.99、-0.87)。
  • 所有纹理特征与组织学类型(浸润性导管癌 vs 浸润性小叶癌)显著相关(0.02<P<0.03)。
  • SUVmax和TLG能预测新辅助化疗病理反应(P=0.0021和P=0.02),纹理特征未能预测。

核心结论

  • 纹理特征与SUV参数相关性差,与MTV相关性高;纹理特征与组织学类型显著相关;SUVmax和TLG能预测新辅助化疗反应,纹理特征未能预测。

研究设计与样本

  • 前瞻性、同质性队列研究,纳入171例无远处转移的较大或局部晚期雌激素受体阳性乳腺癌连续患者,新辅助化疗前行18F-FDG PET检查。
  • 原发肿瘤采用自适应阈值分割法勾画,测量体积、强度及纹理参数(熵、均匀性、对比度、能量),并与治疗前乳腺活检确定的肿瘤特征比较。

主要发现

  • SUVmax与纹理特征(熵、均匀性、能量、对比度)的Spearman系数分别为0.43、0.24、-0.43和-0.15。
  • MTV与纹理特征(熵、均匀性、能量、对比度)的Spearman系数分别为0.99、0.86、-0.99和-0.87。
  • 所有纹理特征与组织学类型(浸润性导管癌 vs 浸润性小叶癌)显著相关(0.02<P<0.03),但与免疫组化特征无显著关联。
  • SUVmax和TLG预测病理反应(分别为P=0.0021和P=0.02);纹理特征(熵、均匀性、能量、对比度)未预测病理反应(分别为P=0.27、0.19、0.94、0.19)。

关键数值与推荐

  • SUVmax与熵、均匀性、能量、对比度的Spearman系数分别为0.43、0.24、-0.43和-0.15。
  • MTV与熵、均匀性、能量、对比度的Spearman系数分别为0.99、0.86、-0.99和-0.87。
  • 纹理特征与组织学类型相关(0.02<P<0.03),与免疫组化特征无显著关联。
  • SUVmax预测病理反应P=0.0021,TLG预测病理反应P=0.02;纹理特征预测病理反应P值分别为熵0.27、均匀性0.19、能量0.94、对比度0.19。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The study was designed to evaluate 1) the relationship between PET image textural features (TFs) and SUVs, metabolic tumour volume (MTV), total lesion glycolysis (TLG) and tumour characteristics in a large prospective and homogenous cohort of oestrogen receptor-positive (ER+) breast cancer (BC) patients, and 2) the capability of those parameters to predict response to neoadjuvant chemotherapy (NAC). METHODS: 171 consecutive patients with large or locally advanced ER+ BC without distant metastases underwent an 18F-FDG PET examination before NAC. The primary tumour was delineated with an adaptive threshold segmentation method. Parameters of volume, intensity and texture (entropy, homogeneity, contrast and energy) were measured and compared with tumour characteristics determined on pre-treatment breast biopsy (Wilcoxon rank-sum test). The correlation between PET-derived parameters was determined using Spearman's coefficient. The relationship between PET features and pathological findings was determined using the Wilcoxon rank-sum test. RESULTS: Spearman's coefficients between SUVmax and TFs were 0.43, 0.24, -0.43 and -0.15 respectively for entropy, homogeneity, energy and contrast; they were higher between MTV and TFs: 0.99, 0.86, -0.99 and -0.87. All TFs showed a significant association with the histological type (IDC vs. ILC; 0.02 < P < 0.03) but didn't with immunohistochemical characteristics. SUVmax and TLG predicted the pathological response (P = 0.0021 and P = 0.02 respectively); TFs didn't (P: 0.27, 0.19, 0.94, 0.19 respectively for entropy, homogeneity, energy and contrast). CONCLUSIONS: The correlation of TFs was poor with SUV parameters and high with MTV. TFs showed a significant association with the histological type. Finally, while SUVmax and TLG were able to predict response to NAC, TFs failed.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lemarignier C, Martineau A, Teixeira L, et al. Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients. Eur J Nucl Med Mol Imaging. 2017. PMID: 28188325. doi:10.1007/s00259-017-3641-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。